Recalls / Active ingredient / Liraglutide
Liraglutide
3 FDA drug recalls involving the active ingredient “Liraglutide” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-22 | Class II | Saxenda (liraglutide) Injection, 18 mg/3 mL (6 mg/mL), 1 x 3 mL Prefilled Pen, Sample. Not for Resale., Rx onl | Novo Nordisk Inc |
| 2021-03-22 | Class II | ViCTOZA (liraglutide) injection, 18 mg/3 mL (6 mg/mL), contains: 1 Victoza Pen, Sample Not for Resale, Rx only | Novo Nordisk Inc |
| 2021-03-22 | Class I | Xultophy 100/3.6 (insulin degludec and liraglutide injection), 100 units/mL and 3.6 mg/mL, 3 mL Prefilled Pen, | Novo Nordisk Inc |